A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema
Clinical trial NCT06929143 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06929143
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-04-14
- Primary completion
- 2027-07-30
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.